194 related articles for article (PubMed ID: 33406505)
1. Decreased miR-132 plays a crucial role in diabetic encephalopathy by regulating the GSK-3β/Tau pathway.
Shi L; Zhang R; Li T; Han X; Yuan N; Jiang L; Zhou H; Xu S
Aging (Albany NY); 2020 Dec; 13(3):4590-4604. PubMed ID: 33406505
[TBL] [Abstract][Full Text] [Related]
2. Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathway.
Wang YJ; Ren QG; Gong WG; Wu D; Tang X; Li XL; Wu FF; Bai F; Xu L; Zhang ZJ
Oncotarget; 2016 Mar; 7(12):13328-39. PubMed ID: 26950279
[TBL] [Abstract][Full Text] [Related]
3. Nimodipine attenuates tau phosphorylation at Ser396 via miR-132/GSK-3β pathway in chronic cerebral hypoperfusion rats.
Tan Z; Chen Y; Xie W; Liu X; Zhu Y; Zhu Y
Eur J Pharmacol; 2018 Jan; 819():1-8. PubMed ID: 29042207
[TBL] [Abstract][Full Text] [Related]
4. MiR-124-3p attenuates hyperphosphorylation of Tau protein-induced apoptosis via caveolin-1-PI3K/Akt/GSK3β pathway in N2a/APP695swe cells.
Kang Q; Xiang Y; Li D; Liang J; Zhang X; Zhou F; Qiao M; Nie Y; He Y; Cheng J; Dai Y; Li Y
Oncotarget; 2017 Apr; 8(15):24314-24326. PubMed ID: 28186985
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3
Yang W; Liu Y; Xu QQ; Xian YF; Lin ZX
Oxid Med Cell Longev; 2020; 2020():4754195. PubMed ID: 32963694
[TBL] [Abstract][Full Text] [Related]
7. Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation.
Zhang Y; Zhang J; Wang E; Qian W; Fan Y; Feng Y; Yin H; Li Y; Wang Y; Yuan T
Toxicol Sci; 2018 Apr; 162(2):475-487. PubMed ID: 29228318
[TBL] [Abstract][Full Text] [Related]
8. MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice.
Jiang Y; Zhang Y; Su L
Neurotox Res; 2020 Aug; 38(2):524-535. PubMed ID: 32415525
[TBL] [Abstract][Full Text] [Related]
9. Ribosylation-Derived Advanced Glycation End Products Induce Tau Hyperphosphorylation Through Brain-Derived Neurotrophic Factor Reduction.
Wu B; Wang Y; Shi C; Chen Y; Yu L; Li J; Li W; Wei Y; He R
J Alzheimers Dis; 2019; 71(1):291-305. PubMed ID: 31381511
[TBL] [Abstract][Full Text] [Related]
10. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
Wu X; Kosaraju J; Tam KY
Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress with tau hyperphosphorylation in memory impaired 1,2-diacetylbenzene-treated mice.
Kang SW; Kim SJ; Kim MS
Toxicol Lett; 2017 Sep; 279():53-59. PubMed ID: 28734998
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS
J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504
[TBL] [Abstract][Full Text] [Related]
14. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.
Li J; Chen W; Yi Y; Tong Q
J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160
[TBL] [Abstract][Full Text] [Related]
15. GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactions.
L'Episcopo F; Drouin-Ouellet J; Tirolo C; Pulvirenti A; Giugno R; Testa N; Caniglia S; Serapide MF; Cisbani G; Barker RA; Cicchetti F; Marchetti B
Cell Death Dis; 2016 Apr; 7(4):e2206. PubMed ID: 27124580
[TBL] [Abstract][Full Text] [Related]
16. Deep Sea Water Alleviates Tau Phosphorylation and Cognitive Impairment via PI3K/Akt/GSK-3β Pathway.
He S; Peng WB; Fu XJ; Zhou HL; Wang ZG
Mar Biotechnol (NY); 2022 Mar; 24(1):68-81. PubMed ID: 34982299
[TBL] [Abstract][Full Text] [Related]
17. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
18. Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
Hou TY; Zhou Y; Zhu LS; Wang X; Pang P; Wang DQ; Liuyang ZY; Man H; Lu Y; Zhu LQ; Liu D
J Neurochem; 2020 Aug; 154(4):441-457. PubMed ID: 31951013
[TBL] [Abstract][Full Text] [Related]
19. Sarsasapogenin attenuates Alzheimer-like encephalopathy in diabetes.
Zhang YM; Zheng T; Huang TT; Gu PP; Gou LS; Ma TF; Liu YW
Phytomedicine; 2021 Oct; 91():153686. PubMed ID: 34333330
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A
Zhao ZA; Zhao Y; Ning YL; Yang N; Peng Y; Li P; Chen XY; Liu D; Wang H; Chen X; Bai W; Chen JF; Zhou YG
Transl Psychiatry; 2017 May; 7(5):e1123. PubMed ID: 28485728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
